Showing results (1561-1570 of 5,257) with videos related to
Sort By:
Pageof 526
Oncology|January 1, 1987
Role of hyperthermic perfusion in the treatment of limb osteogenic sarcomaR Cavaliere, F Di Filippo, F S Santori, et al.Oncology|January 1, 1986
Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloidsT A Khwaja, C B Dias, S PentecostOncology|June 20, 2019
Immuno-Oncological Treatment and Tumor Mass in Non-Small Cell Lung Cancer: Case-Control Analysis of Overall Survival in Routine Clinical PracticeMartin Faehling, Marcel Kopp, Birgit Schwenk, et al.Oncology|July 3, 2019
Special Focus on Stage IV Cervical Cancer Patients: A Decade ExperienceSophie Espenel, Max Adrien Garcia, Julien Langrand-Escure, et al.Oncology|October 11, 2019
The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective GastrectomyTomoyuki Wakahara, Kiyonori Kanemitsu, Sadaki Asari, et al.Oncology|June 27, 2019
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with LenvatinibKenichiro Kodama, Tomokazu Kawaoka, Maiko Namba, et al.Oncology|October 9, 2019
Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIBAmelie de Gregorio, Peter Widschwendter, Florian Ebner, et al.Oncology|February 20, 2022
Efficacy and Safety of Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma and Child-Pugh Class B: A Retrospective Cohort StudyMasatsugu Ishii, Osamu Itano, Hideki Iwamoto, et al.Oncology|February 3, 2022
Response-Guided Omission of Anthracycline in Patients with HER2-Positive Early Breast Cancer Treated with Neoadjuvant Taxane and Trastuzumab: 5-Year Follow-Up of Prognostic Study Using Propensity Score MatchingNoriko Fujita, Koichi Fujita, Seung Jin Kim, et al.Pageof 526